查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1714335

黏液补充剂市场－全球产业规模、份额、趋势、机会和预测（按产品类型、最终用途、地区和竞争情况细分，2020-2030 年预测）

Viscosupplementation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By End Use By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 184 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年黏液补充剂市场价值为 47.6 亿美元，预计到 2030 年将达到 76.8 亿美元，复合年增长率为 8.25%。这种增长主要归因于骨关节炎和其他肌肉骨骼疾病的发生率不断增加，尤其是在老年人口中。黏液补充疗法是将透明质酸溶液注射到关节中，它为外科手术提供了一种微创的替代方法，可以增强活动能力并减轻关节疼痛。产品开发的进步以及应用范围从膝关节骨性关节炎扩展到其他关节的扩大进一步支持了市场的发展。运动相关损伤病例的增加以及全球转向非手术治疗方案的转变也刺激了需求。然而，高昂的治疗费用和不一致的保险报销政策继续阻碍一些地区的广泛采用。

市场概览
预测期 2026-2030
2024年市场规模 47.6亿美元
2030年市场规模 76.8亿美元
2025-2030 年复合年增长率 8.25%
成长最快的领域 三次注射
最大的市场 亚太地区

关键市场驱动因素

人口老化加剧

主要市场挑战

治疗费用高

主要市场趋势

生物相容性透明质酸（HA）衍生物

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：黏液补充剂市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 依产品类型（单次注射、三次注射、五次注射）
    • 依最终用途（医院、骨科诊所/ASC）
    • 按地区
    • 按公司分类（2024）
  • 市场地图

第六章：北美黏弹性补充市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第七章：欧洲黏液补充剂市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲：国家分析
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙

第八章：亚太黏弹性补充市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：南美洲黏液补充市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第十章：中东与非洲黏液补充市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA：国家分析
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章：市场动态

  • 驱动程式
  • 挑战

第 12 章：市场趋势与发展

  • 最新动态
  • 产品发布
  • 併购

第 13 章： 大环境分析

第 14 章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品的威胁

第 15 章：全球黏液补充剂市场：SWOT 分析

第 16 章：竞争格局

  • Sanofi SA
  • Seikagaku Corporation
  • Smith & Nephew PLC.
  • Lifecore Biomedical, LLC.
  • Fidia Farmaceutici SpA
  • F.Hoffmann-La Roche Ltd.
  • LG Life Sciences Ltd.
  • Ferring Pharmaceutical BV
  • Zimmer Biomet Holdings Inc
  • Anika Therapeutics, Inc.

第 17 章：策略建议

第18章调查会社について・免责事项

简介目录
Product Code: 16098

The Viscosupplementation Market was valued at USD 4.76 billion in 2024 and is projected to reach USD 7.68 billion by 2030, growing at a CAGR of 8.25%. This growth is primarily attributed to the increasing incidence of osteoarthritis and other musculoskeletal disorders, particularly among the aging population. Viscosupplementation, which involves injecting hyaluronic acid-based solutions into joints, offers a minimally invasive alternative to surgical interventions, enhancing mobility and reducing joint pain. The market is further supported by advancements in product development and the broadening of applications beyond knee osteoarthritis to other joints. Rising cases of sports-related injuries and the global shift toward non-surgical treatment options have also fueled demand. However, high treatment costs and inconsistent insurance reimbursement policies continue to pose barriers to widespread adoption in some regions.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 4.76 Billion
Market Size 2030USD 7.68 Billion
CAGR 2025-20308.25%
Fastest Growing SegmentThree-injection
Largest MarketAsia Pacific

Key Market Drivers

Rising Aging Population

One of the most influential factors driving growth in the global viscosupplementation market is the rising aging population. According to the United Nations Department of Economic and Social Affairs, the global population aged 60 and above is projected to reach 2.1 billion by 2050, up from 1.2 billion in 2024. This age group is highly susceptible to osteoarthritis (OA), a major condition treated with viscosupplementation. Statistics show that 43% of individuals with OA are aged 65 or older, while 88% are aged 45 or older. The 55-64 age group reports the highest annual incidence of knee OA, positioning them as a key demographic for viscosupplementation therapy. As this segment of the population grows, so does the demand for effective, non-surgical joint treatments to improve mobility and quality of life. This demographic trend supports the long-term expansion of the viscosupplementation market.

Key Market Challenges

High Treatment Cost

The elevated cost of viscosupplementation treatments presents a major challenge for market expansion. These treatments often require multiple injections over time, especially for chronic conditions like osteoarthritis, leading to recurring expenses. This becomes a financial burden for patients lacking sufficient insurance coverage and creates reimbursement hurdles for healthcare providers. In some healthcare systems, limited insurance policies or delays in reimbursement further deter the adoption of these therapies. The high cost may prompt patients to pursue more affordable alternatives such as medications or physical therapy. To mitigate this issue, the market must focus on enhancing cost-efficiency through pricing strategies, improved insurance coverage, and patient education regarding the long-term benefits of viscosupplementation over other management options for joint pain.

Key Market Trends

Biocompatible Hyaluronic Acid (HA) Derivatives

A notable trend in the Viscosupplementation Market is the increasing development and use of biocompatible hyaluronic acid (HA) derivatives. These derivatives are engineered to replicate the properties of natural HA more closely, offering longer-lasting joint lubrication and improved pain relief. By minimizing injection frequency and maximizing therapeutic outcomes, these products enhance patient compliance and comfort. Additionally, their improved safety profile-due to a lower likelihood of adverse reactions-makes them more favorable for long-term use. Patients benefit from extended relief and reduced joint inflammation, resulting in better mobility and higher satisfaction. Manufacturers are investing in research to develop advanced HA derivatives that offer more effective, durable, and convenient treatment options. This trend is expected to reshape osteoarthritis care by providing innovative solutions that improve patient outcomes and treatment experiences.

Key Market Players

  • Sanofi SA
  • Seikagaku Corporation
  • Smith & Nephew PLC.
  • Lifecore Biomedical, LLC.
  • Fidia Farmaceutici S.p.A
  • F. Hoffmann-La Roche Ltd.
  • LG Life Sciences Ltd.
  • Ferring Pharmaceutical B.V.
  • Zimmer Biomet Holdings Inc
  • Anika Therapeutics, Inc.

Report Scope:

In this report, the Global Viscosupplementation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Viscosupplementation Market, By Product Type:

  • Single Injection
  • Three Injection
  • Five Injection

Viscosupplementation Market, By End User:

  • Hospitals
  • Orthopedic Clinics/ASCs

Viscosupplementation Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Viscosupplementation Market.

Available Customizations:

Global Viscosupplementation market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Viscosupplementation Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Single Injection, Three Injection, Five Injection)
    • 5.2.2. By End Use (Hospitals, Orthopedic Clinics/ASCs)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Viscosupplementation Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By End Use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Viscosupplementation Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By End Use
    • 6.3.2. Canada Viscosupplementation Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By End Use
    • 6.3.3. Mexico Viscosupplementation Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By End Use

7. Europe Viscosupplementation Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By End Use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Viscosupplementation Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By End Use
    • 7.3.2. United Kingdom Viscosupplementation Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By End Use
    • 7.3.3. Italy Viscosupplementation Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By End Use
    • 7.3.4. France Viscosupplementation Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By End Use
    • 7.3.5. Spain Viscosupplementation Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By End Use

8. Asia-Pacific Viscosupplementation Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By End Use
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Viscosupplementation Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By End Use
    • 8.3.2. India Viscosupplementation Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By End Use
    • 8.3.3. Japan Viscosupplementation Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By End Use
    • 8.3.4. South Korea Viscosupplementation Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By End Use
    • 8.3.5. Australia Viscosupplementation Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By End Use

9. South America Viscosupplementation Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By End Use
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Viscosupplementation Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By End Use
    • 9.3.2. Argentina Viscosupplementation Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By End Use
    • 9.3.3. Colombia Viscosupplementation Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By End Use

10. Middle East and Africa Viscosupplementation Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By End Use
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Viscosupplementation Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By End Use
    • 10.3.2. Saudi Arabia Viscosupplementation Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By End Use
    • 10.3.3. UAE Viscosupplementation Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Product

15. Global Viscosupplementation Market: SWOT Analysis

16. Competitive Landscape

  • 16.1. Sanofi SA
    • 16.1.1. Business Overview
    • 16.1.2. Product & Service Offerings
    • 16.1.3. Recent Developments
    • 16.1.4. Financials (If Listed)
    • 16.1.5. Key Personnel
    • 16.1.6. SWOT Analysis
  • 16.2. Seikagaku Corporation
  • 16.3. Smith & Nephew PLC.
  • 16.4. Lifecore Biomedical, LLC.
  • 16.5. Fidia Farmaceutici S.p.A
  • 16.6. F.Hoffmann-La Roche Ltd.
  • 16.7. LG Life Sciences Ltd.
  • 16.8. Ferring Pharmaceutical B.V.
  • 16.9. Zimmer Biomet Holdings Inc
  • 16.10.Anika Therapeutics, Inc.

17. Strategic Recommendations

18. About Us & Disclaimer